| Literature DB >> 15545183 |
Kjell Oberg1, Lone Astrup, Barbro Eriksson, Sture E Falkmer, Ursula G Falkmer, Jens Gustafsen, Caj Haglund, Ulrich Knigge, Morten H Vatn, Matti Välimäki.
Abstract
Part II of the guidelines contains a description of epidemiology, histopathology, clinical presentation, diagnostic procedure, treatment, and survival for each type of neuroendocrine tumour. We are not only including gastroenteropancreatic tumours but also bronchopulmonary and thymic neuroendocrine tumours. These guidelines essentially cover basic knowledge in the diagnosis and management of the different forms of neuroendocrine tumour. We have, however, tried to give more updated information about the epidemiology and histopathology, which is essential for the clinical management of these tumours.Entities:
Mesh:
Year: 2004 PMID: 15545183 DOI: 10.1080/02841860410018584
Source DB: PubMed Journal: Acta Oncol ISSN: 0284-186X Impact factor: 4.089